In November the Tenth Conference of the Parties (#COP10) to the Framework Convention on Tobacco Control (FCTC) will meet in Panama, with the fate of safer nicotine products hanging in the balance. Harry Shapiro joins us to shed some light on these closed-door proceedings, and how these meetings will inevitably impact tobacco harm reduction efforts around the globe.

Read the GSTHR #COP10 Briefing Paper here: https://gsthr.org/resources/briefing-papers/the-fctc-cop10-agenda-and-supporting-documents/

While the United States of America is ground zero for the anti-vaping propaganda and misinformation that poisoned worldwide public perception of vaping, it’s also home to a solid and relentless vaping advocacy community pushing back against the anti-vaping hordes. How are they doing? Find out in this episode of GFN Interviews.

Featuring:

Allison Boughner

Vice President, American Vapor Manufacturers

Marketing & Communications Director, ECIG Charleston

@alli_vapes

@vapouramerican

ecigcharleston.com

Nicotine pouches have enabled Sweden to reach "smoke-free" status, and have shown how safer nicotine products could help reduce the global health burden associated with smoking and high-risk tobacco products. In this episode, Carissa Düring discusses the rise of nicotine pouches and how the Swedish approach could serve as a model for the rest of the world.

GFN Voices with Carmen Escrig, Samrat Chowdhery and many more famous faces from #GFN23 by GFN.TV

GFN Voices with David Burns & Karen Potter #GFN23 by GFN.TV

There is a particular piece of information you are not supposed to talk about. You certainly can't promote it. And never depend on public health to acknowledge it. What is it? Nicotine is not carcinogenic; when consumed outside of a cigarette, it is benign. Likely no more harmful than caffeine. According to harm reduction consultant and developmental neurobiologist Charles Gardner, nicotine could have significant health benefits.

Featuring:

CHARLES A. GARDNER, PhD

Consultant, Harm Reduction Strategies

Developmental Neurobiologist

@ChaunceyGardner

In this episode Chimwemwe Ngoma, a leading tobacco harm reduction advocate from Malawi, discusses a recent study examining attitudes to THR in African online news media, and how a lack of consensus amongst global public health authorities stokes confusion amongst smokers and users of safer products.

Click here to read the study discussed in today's episode:

GFN Voices with Eleni Diamantopoulou #GFN23 by GFN.TV

In this episode of GFN News, Pritika Kumar discusses a recent study looking at how THR and safer products are viewed by frontline health and social care workers, and how a revolution in THR training amongst frontline professionals could be a crucial step in reducing smoking rates in at-risk groups.

There is too much emotion driving public policy on e-cigarettes, says leading tobacco control researcher Dr. Jasjit Ahluwalia. A physician, public health scientist, and professor at Brown University’s Schools of Public Health and Medicine, Dr. Ahluwalia has deep experience researching health disparities and smoking cessation and nicotine addiction in African-American smokers. He has been continuously funded by the NIH for 25 years and has published over 400 manuscripts. Hear his assessment on the efficacy and relative safety of e-cigarettes and other safer nicotine products.

Featuring:

DR. Jasjit Ahluwalia

Physician, Public Health Scientist

Prof. Behavioral and Social Sciences & Internal Medicine Center for Alcohol & Addiction Studies

Brown University School of Public Health

@Brown_SPH